Corporate calendar for CG Oncology Inc. (CGON): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in...
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | ||
| 2026-09-15 | $-0.00 | |
| 2026-09-15 | ||
| 2026-09-15 |
Price
| Price | $74.12 |
| Market Cap | $6.5B |
| Exchange | NASDAQ |
| Country | US |
Related companies: AAPG · APGE · CELC · CNTA · IRON · LEGN · RARE
Explore sector: Healthcare · Biotechnology
More sections of CGON: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks